The Breast
Volume 19, Issue 4 , Pages 284-288 , August 2010

Cost-benefit analysis of using large-format histology sections in routine diagnostic breast care

  • Tibor Tot

      Affiliations

    • Corresponding Author InformationTel.: +46 23 492 696; fax: +46 23 492 389.

References 

  1. Gallager HS, Martin JE. The study of mammary carcinoma by mammography and whole organ sectioning. Cancer. 1969;23:855–873
  2. Egan RI. Multicentric breast carcinomas: clinical – radiographic-pathologic whole organ studies and 10-year survival. Cancer. 1982;49:1123–1130
  3. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979–990
  4. Luttges J, Kalbfleisch H, Prinz P. Nipple involvement and multicentricity in breast cancer. A study of whole organ sections. J Cancer Res Clin Oncol. 1987;113:481–487
  5. Fochsini MP, Tot T, Eusebi V. Large section (macrosection) histologic slides. In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. 2nd ed. Philadelphia: Lippincott, Williams and Wilkins; 2002;p. 249–254
  6. Tot T. The clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histological sections. Cancer. 2007;110:2551–2560
  7. Tot T. The metastastic capacity of multifocal breast carcinomas: extensive tumors versus tumors of limited extent. Hum Pathol. 2009;40:199–205
  8. Holland R, Hendricks JH, Vebeek AL, Mravunac M, Schuurman S, Stekhoven JH. Extent, distribution, and mammographic/histological correlation of breast ductal carcinoma in situ. Lancet. 1990;335:519–522
  9. Faverly DRG, Hendricks JHCL, Holland R. Breast carcinoma of limited extent. Frequency, radiologic – pathologic characteristics, and surgical margin requirements. Cancer. 2001;91:647–659
  10. Tot T, Pekár G, Hofmeyer S, Sollie T, Gere M, Tarján M. The distribution of the lesions in 1–14-mm invasive breast carcinomas and its relation to metastatic potential. Virchows Arch. 2009;455:109–115
  11. Jackson PA, Merchant W, McCormick CJ, Cook MG. A comparison of large block macrosectioning and conventional techniques in breast pathology. Virchows Arch. 1994;425:243–248
  12. Tucker FL. New era in pathologic techniques in diagnosing and reporting breast cancers. Semin Breast Dis. 2008;11:140–147
  13. Tot T, Tabár L, Dean PB. Practical breast pathology. Stuttgart – New York: Thieme; 2002;p. 116–23
  14. Tot T. Colorectal tumors. Atlas of large section histopathology. Stuttgart – New York: Thieme; 2005;p. 129–44
  15. Tabár L, Tot T, Dean PB. Breast cancer, the art and science of early detection with mammography. Stuttgart – New York: Thieme; 2005;p. 405–38
  16. Mechine-Neuville A, Chenard MP, Gairard B, Mathelin C, Bellocq JP. Large sections in routine breast pathology. A technique adapted to conservative surgery. Ann Pathol. 2000;20:275–279
  17. Sun L, Wang D, Zubovits JT, Yaffe MJ, Clarke GM. An improved processing method for breast whole-mount serial sections for three-dimensional histopathology imaging. Am J Clin Pathol. 2009;131:383–392
  18. In:  Tavassoli FA,  Eusebi V editor. Tumors of the mammary gland. AFIP atlas of tumor pathology series. vol. 4:Maryland: ARP Press; 2009;p. 404–405
  19. Tot T, Tabár L. Radio-pathologic correlation of ductal carcinoma in situ of the breast using two- and three-dimensional large histologic sections. Semin Breast Dis. 2005;8:144–151
  20. Biesemier KW, Alexander CM. Enhancement of mammographic-pathologic correlation utilizing large format histology for malignant breast diseases. Semin Breast Dis. 2005;8:152–162
  21. Tot T, Gere M. Radiological – pathological correlation in diagnosing breast carcinoma: the role of pathology in the multimodality era. Pathol Oncol Res. 2008;14:173–178
  22. Tot T. DCIS, cytokeratins and the theory of the sick lobe. Virchows Arch. 2005;447:1–8
  23. Agelopoulos K, Buerger H, Brandt B. Allelic imbalance of the egfr gene as key event in breast cancer progression – the concept of committed progenitor cells. Curr Cancer Drug Targets. 2008;8:431–445
  24. Heaphy CM, Griffith JK, Bisoffi M. Mammary field cancerization: molecular evidence and clinical importance. Breast Cancer Res Treat. Aug 2009;15:epub ahead PMID: 19685287

PII: S0960-9776(10)00069-X

doi: 10.1016/j.breast.2010.03.015

The Breast
Volume 19, Issue 4 , Pages 284-288 , August 2010

Article Tools

* Image Usage & Resolution